Potent small molecule inhibitors of spleen tyrosine kinase (Syk)
摘要:
A series of oxindoles demonstrating inhibition of the pbosphorylation of biotinylated substrates of Syk and IgE/FcepsilonRI triggered basophil cell degranulation has been identified. A study of the SAR around sulfonamide 31 (IC50=5 nM, EC50= 1400 nM) is discussed. The modest cellular activity representative of the sulfonamide series was overcome when the Polar surface Area was lowered to < 110 Angstrom(2), leading to the identification of amide 32 (IC50= 145 nM, EC50= 100 nM). (C) 2003 Published by Elsevier Ltd.
Potent small molecule inhibitors of spleen tyrosine kinase (Syk)
摘要:
A series of oxindoles demonstrating inhibition of the pbosphorylation of biotinylated substrates of Syk and IgE/FcepsilonRI triggered basophil cell degranulation has been identified. A study of the SAR around sulfonamide 31 (IC50=5 nM, EC50= 1400 nM) is discussed. The modest cellular activity representative of the sulfonamide series was overcome when the Polar surface Area was lowered to < 110 Angstrom(2), leading to the identification of amide 32 (IC50= 145 nM, EC50= 100 nM). (C) 2003 Published by Elsevier Ltd.
3- (AMINOMETHYLIDEN) 2-INDOLINONE DERIVATIVES AND THEIR USE AS CELL PROLIFERATION INHIBITORS
申请人:Boehringer Ingelheim International GmbH
公开号:EP2016049A1
公开(公告)日:2009-01-21
[EN] 3- (AMINOMETHYLIDEN) 2-INDOLINONE DERIVATIVES AND THEIR USE AS CELL PROLIFERATION INHIBITORS<br/>[FR] DÉRIVÉS DE 3- (AMINOMÉTHYLIDÈNE) 2-INDOLINONE ET LEUR UTILISATION EN TANT QU'INHIBITEURS DE LA PROLIFÉRATION CELLULAIRE
申请人:BOEHRINGER INGELHEIM INT
公开号:WO2007122219A1
公开(公告)日:2007-11-01
[EN] The present invention encompasses compounds of general formula (1) wherein R1, R2, R3 and X are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for preparing a pharmaceutical composition having the above-mentioned properties. [FR] La présente invention comprend des composés de formule générale (1), dans laquelle R1, R2, R3 et X sont tels que définis dans la revendication 1, qui sont appropriés pour le traitement des maladies caractérisées par une prolifération cellulaire excessive ou anormale, et leur utilisation pour préparer une composition pharmaceutique présentant les propriétés mentionnées ci-dessus.
10.1007/s00044-024-03259-3
作者:Sulaibi, Mazen Al、Zahra, Jalal、Bardaweel, Sanaa、El Abadleh, Mustafa、Taha, Mutasem O.
DOI:10.1007/s00044-024-03259-3
日期:——
Potent small molecule inhibitors of spleen tyrosine kinase (Syk)
A series of oxindoles demonstrating inhibition of the pbosphorylation of biotinylated substrates of Syk and IgE/FcepsilonRI triggered basophil cell degranulation has been identified. A study of the SAR around sulfonamide 31 (IC50=5 nM, EC50= 1400 nM) is discussed. The modest cellular activity representative of the sulfonamide series was overcome when the Polar surface Area was lowered to < 110 Angstrom(2), leading to the identification of amide 32 (IC50= 145 nM, EC50= 100 nM). (C) 2003 Published by Elsevier Ltd.